These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8842508)

  • 1. Electrophysiologic mechanisms of adverse effects of class I antiarrhythmic drugs (cibenzoline, pilsicainide, disopyramide, procainamide) in induction of atrioventricular re-entrant tachycardia.
    Fujiki A; Tani M; Yoshida S; Inoue H
    Cardiovasc Drugs Ther; 1996 May; 10(2):159-66. PubMed ID: 8842508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic effects and efficacy of cibenzoline in patients with supraventricular tachycardia.
    Fujiki A; Mizumaki K; Tani M; Yoshida S; Sasayama S
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):375-9. PubMed ID: 1279281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
    Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
    Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.
    Prystowsky EN; Klein GJ; Rinkenberger RL; Heger JJ; Naccarelli GV; Zipes DP
    Circulation; 1984 Feb; 69(2):278-87. PubMed ID: 6418407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical electrophysiologic effects of lorcainide in patients and its effect on the conduction of accessory pathway in Wolff-Parkinson-White syndrome].
    Jiang H
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Jun; 18(3):157-9, 190. PubMed ID: 2086169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accessory pathway reciprocating tachycardia.
    Obel OA; Camm AJ
    Eur Heart J; 1998 May; 19 Suppl E():E13-24, E50-1. PubMed ID: 9717020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intravenous amiodarone on electrophysiologic variables and on the modes of termination of atrioventricular reciprocating tachycardia in Wolff-Parkinson-White syndrome.
    Kuga K; Yamaguchi I; Sugishita Y
    Jpn Circ J; 1999 Mar; 63(3):189-95. PubMed ID: 10201620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of intracardiac recordings to determine the site of drug action in paroxysmal supraventricular tachycardia.
    Jackman WM; Friday KJ; Fitzgerald DM; Yeung-Lai-Wah JA; Lazzara R
    Am J Cardiol; 1988 Dec; 62(19):8L-19L. PubMed ID: 3059792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atrioventricular reciprocating tachycardia with QRS type left branch block in patients undergoing radiofrequency catheter ablation: analysis of the substrate and mechanism of tachycardia].
    De Ponti R; Storti C; Salerno-Uriarte JA; Stanke A; Longobardi M; Ferrari AA; Zardini M
    G Ital Cardiol; 1994 Jun; 24(6):707-21. PubMed ID: 8088470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of invasive and non-invasive electrophysiologic studies in the selection of antiarrhythmic drugs for the patients with paroxysmal supraventricular tachyarrhythmia.
    Satake S; Hiejima K; Moroi Y; Hirao K; Kubo I; Suzuki F; Suzuki F
    Jpn Circ J; 1985 Mar; 49(3):345-50. PubMed ID: 3981793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency current catheter ablation of accessory atrioventricular pathways.
    Trajkov I; Kovacevic D; Boskov V; Poposka L; Gjorgov N
    Prilozi; 2006 Dec; 27(2):71-87. PubMed ID: 17211293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encainide for treatment of atrioventricular reciprocating tachycardia in the Wolff-Parkinson-White syndrome.
    Miles WM; Zipes DP; Rinkenberger RL; Markel ML; Prystowsky EN; Dougherty AH; Heger JJ; Naccarelli GV
    Am J Cardiol; 1988 Dec; 62(19):20L-25L. PubMed ID: 3144163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phase 3 and phase 4 block in the accessory pathway].
    Fujiki A; Yoshida S; Tani M; Mizumaki K; Tsuji H; Sasayama S
    J Cardiol; 1990; 20(1):217-25. PubMed ID: 2093755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive effect of SUN1165 on supraventricular tachycardia.
    Terazawa T; Suzuki M; Goto T; Kato R; Hayashi H; Ito A; Isikawa S; Sotobata I
    Am Heart J; 1991 May; 121(5):1437-44. PubMed ID: 2017976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of atropine and isoproterenol on tachycardia induction in asymptomatic patients with Wolff-Parkinson-White electrocardiographic pattern.
    Kim YH; Leitch JW; Klein GJ; Yee R; Leather RA
    Can J Cardiol; 1992 Sep; 8(7):716-20. PubMed ID: 1422992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia.
    Chen SA; Chiang CE; Tai CT; Lee SH; Chiou CW; Ueng KC; Wen ZC; Cheng CC; Chang MS
    Circulation; 1996 Jun; 93(11):2023-32. PubMed ID: 8640978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-wave reentry in orthodromic atrioventricular reciprocating tachycardia: paradoxical shortening of the tachycardia cycle length with development of ipsilateral bundle branch block.
    Coromilas J; Kassotis J; Dizon J; Reiffel J; Costeas C; Lipka L
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8):845-54. PubMed ID: 9727663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic characteristics, electropharmacologic responses and radiofrequency ablation in patients with decremental accessory pathway.
    Chen SA; Tai CT; Chiang CE; Lee SH; Wen ZC; Chiou CW; Ueng KC; Chen YJ; Yu WC; Huang JL; Chang MS
    J Am Coll Cardiol; 1996 Sep; 28(3):732-7. PubMed ID: 8772764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of atrioventricular junctional tachycardia. Role of reentry and concealed accessory bypass tracts.
    Barold SS; Fracp MB; Coumel P
    Am J Cardiol; 1977 Jan; 39(1):97-106. PubMed ID: 831431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia].
    Pfitzner P; Manz M; Schütz R; Lüderitz B
    Z Kardiol; 1989 Oct; 78(10):654-60. PubMed ID: 2686252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.